Nanosphere, Inc. Announces the Closing of Common Stock Offering
27 oct. 2014 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the closing of...
Nanosphere Prices $20 Million Public Offering of Common Stock
22 oct. 2014 09h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere Announces Commencement of Public Offering of Common Stock; Preliminary Third Quarter 2014 Top Line Results
21 oct. 2014 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company" or "Nanosphere") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced...
FDA Clears Additional Viral Targets on Verigene Enteric Pathogens Test
13 oct. 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has received 510(k)...
New Outcomes Data Presented at ICAAC 2014 Further Validates Clinical and Economic Utility of Nanosphere's Verigene Blood Culture Test
08 sept. 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced that data from three outcomes studies...
Nanosphere Announces Review of Strategic Alternatives
04 sept. 2014 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that the Company has...
New Clinical and Economic Outcome Data for Verigene Blood Culture Test to Be Presented at ICAAC 2014
02 sept. 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that three outcomes studies...
Nanosphere Appoints Kristopher Wood to Its Board of Directors
20 août 2014 16h01 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 20, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the appointment of Kristopher...
Nanosphere Announces Second Quarter Financial and Operating Results
06 août 2014 16h01 HE
|
Nanosphere, Inc.
Corporate Highlights and Business Guidance:
Added 37 new Verigene® System customer placements
Achieved Q2 2014 revenues of $2.7 million, a 44% increase over Q2 2013
Increased...
Nanosphere to Release Second Quarter Results and Host Investor Conference Call on Wednesday, August 6, 2014
23 juil. 2014 08h00 HE
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...